1. Home
  2. CBUS vs QSI Comparison

CBUS vs QSI Comparison

Compare CBUS & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.63

Market Cap

142.7M

Sector

Industrials

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.77

Market Cap

165.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBUS
QSI
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.7M
165.6M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CBUS
QSI
Price
$1.63
$0.77
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$9.00
$1.00
AVG Volume (30 Days)
92.9K
2.1M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
74.33
28.17
EPS
N/A
N/A
Revenue
$3,639,000.00
$2,436,000.00
Revenue This Year
$112.72
N/A
Revenue Next Year
$83.18
$618.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.69
52 Week High
$4.19
$3.10

Technical Indicators

Market Signals
Indicator
CBUS
QSI
Relative Strength Index (RSI) 50.07 49.69
Support Level $1.64 $0.70
Resistance Level $1.82 $0.79
Average True Range (ATR) 0.09 0.03
MACD 0.01 0.00
Stochastic Oscillator 82.76 57.55

Price Performance

Historical Comparison
CBUS
QSI

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: